Third Harmonic Bio Inc. (THRD) Stock
THRD is no longer traded. Third Harmonic Bio was delisted from the Nasdaq in July 2025.
Prices on this page are historical; the last trade was July 30, 2025 at $5.38.
Third Harmonic Bio stock price history
THRD final trading statistics
- Final close
- $5.38
- Final trading day
- Jul 30, 2025
- Market cap at delisting
- $242.79M
- Shares outstanding
- 45.13M
- Final 52-week range
- $3.18 – $16.02
- Avg. volume (final 3 mo.)
- 278,497
- All-time high (split-adj.)
- $23.97 · Oct 2022
- All-time low (split-adj.)
- $3.25 · Feb 2025
- Return since IPO
- -68.4%
- Beta
- 2.13
- Book value / share
- $6.06
- Price / book
- 0.89
Third Harmonic Bio annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | $45.5M | -$1.09 |
| FY2023 | $0.00 | -$30.8M | -$0.98 |
| FY2022 | $0.00 | -$37.7M | -$1.22 |
| FY2021 | $0.00 | -$29.6M | — |
| FY2020 | $0.00 | -$12.8M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Third Harmonic Bio Inc.
Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It also develops THB335, an oral small molecule KIT inhibitor for the treatment of mast cell-mediated inflammatory diseases, respiratory, and gastrointestinal conditions. It has a license agreement with Novartis Pharma AG. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in San Francisco, California.
Third Harmonic Bio stock FAQ
What happened to Third Harmonic Bio stock?
Third Harmonic Bio stock was delisted from the Nasdaq. Its final close was $5.38 on July 30, 2025.
Is THRD stock still trading?
No. THRD was delisted from the Nasdaq in July 2025 and no longer trades on a U.S. exchange.
What was the last price of THRD stock?
THRD closed at $5.38 on its final trading day, July 30, 2025, for a market value of about $242.79M.
What were Third Harmonic Bio's revenue and earnings in its last full fiscal year?
Third Harmonic Bio reported revenue of $0.00 and net income of $45.5M in fiscal 2024, its last full year as a public company.
When did Third Harmonic Bio go public?
Third Harmonic Bio Inc. stock began trading on September 14, 2022.